Your creatinine is 1.3 mg/dL and your eGFR is 58. According to your lab report, you have stage 3 chronic kidney disease. According to your Cystatin C, your kidneys are perfectly healthy. Which one is right? For strength athletes, the answer is almost always Cystatin C. The creatinine-based eGFR equation was never designed for people with high muscle mass, and it fails systematically in this population.
The Creatinine Problem for Athletes
Creatinine is a waste product of creatine phosphate metabolism in muscle. The more muscle you have, the more creatinine you produce. A 70 kg sedentary individual and a 100 kg bodybuilder with identical kidney function will have very different creatinine levels — not because one has healthier kidneys, but because one has more muscle mass producing more creatinine as a metabolic byproduct.
The problem is compounded by training. Exercise within 48-72 hours of a blood draw raises creatinine further due to muscle microtrauma and increased turnover. Add a high-protein diet (which increases creatinine production) and creatine supplementation (which directly increases creatinine levels), and the standard creatinine-based eGFR equation becomes nearly uninterpretable for serious athletes.
This is not a minor issue. A 2020 study in the Clinical Journal of the American Society of Nephrology found that 30-50% of athletes with elevated creatinine were reclassified to normal kidney function when tested with Cystatin C. These are individuals who would otherwise be labeled with chronic kidney disease — with all the associated medical, insurance, and psychological consequences — based on a marker that was never designed to assess kidney function in people with high muscle mass.
🔬Cystatin C reclassifies 30-50% of athletes from CKD stage 3 to normal kidney function. The creatinine-based eGFR is systematically biased in individuals with high muscle mass, and relying on it alone leads to unnecessary diagnostic workup, patient anxiety, and potentially inappropriate lifestyle recommendations.
— CJASN, 2020: Cystatin C Reclassification Study
What Cystatin C Measures
Cystatin C is a cysteine protease inhibitor produced at a constant rate by all nucleated cells in the body. Its production is not affected by muscle mass, diet, exercise, or age. It is freely filtered by the kidney's glomerulus and completely broken down in the proximal tubule. This means its blood level directly reflects the glomerular filtration rate — the gold standard measure of kidney function.
The CKD-EPI Cystatin C equation, which incorporates Cystatin C level plus age and sex, provides a substantially more accurate eGFR than the creatinine-based CKD-EPI equation in populations with atypical body composition. The KDIGO (Kidney Disease: Improving Global Outcomes) guidelines explicitly recommend confirmatory Cystatin C testing when creatinine-based eGFR is between 45 and 59 mL/min in individuals without known kidney disease.
Cystatin C
Practical Interpretation
A normal Cystatin C level is below 1.0 mg/L. Values between 1.0 and 1.2 mg/L are borderline and may warrant monitoring. Values above 1.2 mg/L suggest true kidney function impairment regardless of muscle mass.
The CKD-EPI Cystatin C eGFR equation can be calculated using online calculators. A result above 90 mL/min is normal. Between 60 and 90 mL/min with normal Cystatin C suggests the creatinine-based estimate was falsely low due to muscle mass. Below 60 mL/min on both creatinine and Cystatin C-based equations indicates genuine kidney function reduction that requires investigation.
For AAS users, the most common scenario is: creatinine elevated (1.2-1.5 mg/dL), eGFR 55-75, with a muscular physique. In this scenario, Cystatin C comes back normal in roughly 70% of cases, confirming that the creatinine elevation is muscle-derived and kidney function is intact. The remaining 30% where Cystatin C is also elevated require genuine nephrology evaluation.
When to Order Cystatin C
How to Order Cystatin C
Cystatin C is available through most major lab providers. In the United States, Labcorp and Quest both offer it. In Europe, it is widely available through national health systems and private labs. The test code varies by provider — check with your lab directly. Cost is typically $30-50 and may not be covered by insurance unless ordered for a specific clinical indication.
No special preparation is needed. Unlike creatinine, Cystatin C is not affected by food intake (no fasting required), exercise (no rest days needed), or creatine supplementation. You can draw it at any time, on any day, regardless of your training schedule. This makes it significantly more convenient than a properly timed creatinine measurement.
If your Cystatin C comes back elevated, the next step is a nephrology referral for comprehensive kidney evaluation. Possible causes in AAS users include AAS-induced hypertension causing kidney damage, chronic dehydration, high-dose NSAID use, or pre-existing kidney conditions. Early intervention for true CKD dramatically improves long-term outcomes, and Cystatin C allows you to identify genuine kidney concerns without the muscle mass confounder.